Danaher Corporation announced the launch of a partnership with AstraZeneca to develop and commercialize novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things: the impact oftariffs and related actions recently implemented by the U.S. and other countries, the impact of debt obligations on operations and liquidity, deterioration of or instability in the global economy, the markets serve and the financial markets, uncertainties with respect to the development, deployment, and use of artificial intelligence in the business and products, the impact of global health crises, uncertainties relating to national laws or policies, including laws or policies to protect or promote domestic interests and/or address foreign competition, contractions or growth rates and cyclicality of markets serve, competition, ability to develop and successfully market new products and technologies and expand into new markets, the potential for improve conduct by employees, agents or business partners, compliance with applicable laws and regulations (including rules relating to off-label marketing and other regulations relating to medical devices and the healthcare industry), the results of clinical trials and perceptions thereof, the ability to effectively address cost reductions and other changes in the healthcare industry, the ability to successfully identify and consummate appropriate acquisitions and strategic investments, the ability to integrate the businesses we acquire and achieve the anticipated growth, synergies and other benefits of such acquisitions, contingent liabilities and other risks relating to acquisitions, investments, strategic relationships and expenditures (including tax-related and other contingent liabilities relating to past and future IPOs, split-offs or spin-offs), security breaches or other disruptions of information technology systems or violations of data privacy laws, the impact of data privacy laws, the impacts of potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in tax laws applicable to multinational companies, litigation, regulatory proceedings and other contingent liabilities including intellectual property and environmental, health and safety matters, the rights of the United States government with respect to production capacity in times of national emergency or with respect to intellectual property/production capacity developed using government funding, risks relating to product, service or software defects, product liability and recalls, risks relating to manufacturing operations, the impact of climate change, legal or regulatory measures to address climate change and other sustainability topics and ability to address regulatory requirements or stakeholder expectations relating to climate change and other sustainability topics, risks relating to fluctuations in the cost and availability of the supplies we use (including commodities) and labor we need for our operations, our relationships with and the performance of our channel partners, uncertainties relating to collaboration arrangements with third-parties, the impact of deregulation on demand for our products and services, labor matters and our ability to recruit, retain and motivate talented employees, U.S. and non-U.S. economic, political, geopolitical, legal, compliance, social and business factors (including the impact of elections, regulatory changes or uncertainty and military conflicts), disruptions and other impacts relating to man-made and natural disasters, inflation and the impact of our By-law exclusive forum provisions.
Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the SEC.
